Boston Scientific Corp. (BSX) Tops Q3 EPS by 5c; Issues Mixed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
It Is the Same Old Story at Boston Scientific (BSX)
October 19, 2012 10:06 AM EDTJefferies maintained a Hold rating on Boston Scientific (NYSE: BSX) and raised its price target to $6.00 (from $5.00).
"At its core, the BSX investment story remains the same: weak end markets and completion in the two largest divisions are sapping growth and cost... More
